---
type: "NewsArticle"
title: "Multi-omics analysis proposes stage-linked Parkinson’s biomarker candidates"
description: "A secondary analysis of Parkinson’s Progression Markers Initiative data combined CSF and plasma proteins and metabolites to identify candidate markers. The machine-learning findings are exploratory and need independent clinical validation."
resource: "https://nootropikler.com/news/parkinsons-proteo-metabolomic-stage-biomarkers"
tags: ["research", "brain", "cognition"]
timestamp: 2026-10-05T14:46:07Z
language: "en"
---

# Multi-omics analysis proposes stage-linked Parkinson’s biomarker candidates

A secondary analysis of Parkinson’s Progression Markers Initiative data combined CSF and plasma proteins and metabolites to identify candidate markers. The machine-learning findings are exploratory and need independent clinical validation.

Author: Nootropik News Editorial Team
Published: 2026-10-05T14:46:07Z
Update: 2026-10-05T14:46:07Z
News/source date: 2026-09-04
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

Researchers reanalyzed existing PPMI data: proteomic measurements from 661 people and metabolomic measurements from 1,136. They combined cerebrospinal fluid and plasma features, compared machine-learning classifiers, and examined longitudinal biomarker patterns over follow-up of up to 16 months.

## What the study found

The integrated analysis identified 21 candidate features retained across at least two models, then highlighted eight candidates with possible diagnostic, conversion, or progression patterns. The candidates included proteins and metabolites related to synaptic, immune, and lipid biology.

## Limits and interpretation

This was a secondary computational analysis, not a prospective test of a clinical assay. The candidate panel and stage labels are hypothesis-generating; longitudinal data were incomplete for many markers, and independent cohorts are needed before any clinical use.

## Sources

- [Proteo-metabolomic integration identifies stage-specific candidate biomarkers for Parkinson’s disease](https://doi.org/10.1038/s41531-026-01497-3) — 2026-09-04
